111, Inc. (YI) News
Filter YI News Items
YI News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest YI News From Around the Web
Below are the latest news stories about 111 INC that investors may wish to consider to help them evaluate YI as an investment opportunity.
111, Inc. (NASDAQ:YI) Q3 2023 Earnings Call Transcript111, Inc. (NASDAQ:YI) Q3 2023 Earnings Call Transcript November 30, 2023 Operator: Hello, everyone, and thank you for joining 111’s Conference Call today. On the call today from the company are Dr. Gang Yu, Co-Founder and Executive Chairman; Mr. Junling Liu, Co-Founder, Chairman and CEO; Mr. Luke Chen, CFO and 111’s Major Subsidiary; and Mr. […] |
111, Inc. Announces Third Quarter 2023 Unaudited Financial Results111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced its unaudited financial results for the third quarter ended September 30, 2023. |
3 Top M&A Plays: Lucrative Merger Deals Poised for Big PayoffsIn the US business landscape, strategic mergers and acquisitions often set the stage for remarkable returns for shareholders. |
111 to Announce Third Quarter 2023 Unaudited Financial Results on November 30, 2023 - Conference Call to Follow111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced that it will report its unaudited financial results for the third quarter ended September 30, 2023, before the U.S. market opens on Thursday, November 30, 2023. |
111, Inc. (NASDAQ:YI) Q2 2023 Earnings Call Transcript111, Inc. (NASDAQ:YI) Q2 2023 Earnings Call Transcript August 24, 2023 Operator: Hello, everyone and thank you for joining 111’s Conference Call today. On the call today from the company are Dr. Gang Yu, Co-Founder and Executive Chairman; Dr. Junling Liu, Co-Founder, Chairman, and CEO; Dr. Luke Chen, CEO of 111’s Major Subsidiary; and Dr. […] |
111, Inc. Announces Second Quarter 2023 Unaudited Financial Results111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced its unaudited financial results for the second quarter ended June 30, 2023. |
111 to Announce Second Quarter 2023 Unaudited Financial Results on August 24, 2023 - Conference Call to Follow111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced that it will report its unaudited financial results for the second quarter ended June 30, 2023, before the U.S. market opens on Thursday, August 24, 2023. |
111, Inc. Announces First Quarter 2023 Unaudited Financial Results111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced its unaudited financial results for the first quarter ended March 31, 2023. |
111 to Announce First Quarter 2023 Unaudited Financial Results on June 15, 2023 - Conference Call to Follow111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced that it will report its unaudited financial results for the first quarter ended March 31, 2023, before the U.S. market opens on Thursday, June 15, 2023. |
111, Inc. (NASDAQ:YI) Q4 2022 Earnings Call Transcript111, Inc. (NASDAQ:YI) Q4 2022 Earnings Call Transcript March 24, 2023 Operator: Hello, everyone and thank you for joining 111’s Conference Call today. On the call today from the company are Dr. Gang Yu, Co-Founder and Executive Chairman; Mr. Junling Liu, Co-Founder, Chairman and CEO; Mr. Luke Chen, CFO of 111’s major subsidiary; and Mr. […] |